Science matched to
your indication.
Fidēs brings deep imaging expertise and a growing network of specialist scientists to each therapeutic area — ensuring the right scientific approach for every study.
The right expertise for
every indication.
Early-phase imaging is not generic. The endpoints that matter, the modalities that best capture biological change, and the biomarkers worth tracking are all indication-specific. Fidēs combines in-house scientific depth with a curated KOL network to bring genuinely relevant expertise to each program — whether you are working in GI, oncology, CNS, cardiovascular, renal or metabolic disease.
Gastroenterology
GI (Crohn’s/UC/IBD/Perianal fistula/ EoE)
Fidēs' native scientific home. A decade of GI imaging expertise — IBD, motility disorders, hepatic disease and NASH — with proprietary tools for quantifying movement and function beyond standard sMARIA and MaRIA scoring.
Oncology
Oncology (GI, solid tumor, CRC)
Augmented response endpoints and scientific rigour for early-phase solid tumour programs where standard RECIST measures do not tell the full story.
Women’s Health
Women’s Health (Endo, Adenomyosis, uterine cancer, fibroids etc)
Cardiac function, vasomotion and structural assessment for early development programs requiring imaging insight beyond traditional measures.
Rheumatology
Rheumatology (Sclerosis, scleroderma)
Structural and functional neuroimaging support for early-phase CNS and neurodegeneration programs.
Systemic/Chronic
Systemic/Chronic (Metabolic, bone density, hepatology etc)
Quantitative renal imaging — structure, function and perfusion — for early-phase nephrology and chronic kidney disease studies.
Where would you like to go next?
Capabilities
From study design through to final report — see how Fidēs supports every stage of the imaging lifecycle in early-phase clinical development.
View CapabilitiesAperis
Real-time visibility of imaging data, annotations and analyses throughout your study — built for how scientists actually work in early development.
Explore AperisCase studies
See how our imaging approach has shaped go / no-go decisions across GI, oncology and beyond in real early-phase programs.
Browse Case Studies